Log In
BCIQ
Print this Print this
 

Tbria, Oral salmon calcitonin

Also known as: Oral calcitonin, sCT oral

  Manage Alerts
Collapse Summary General Information
Company Tarsa Therapeutics Inc.
DescriptionOsteoclast inhibitor
Molecular Target Calcitonin receptor
Mechanism of ActionCalcitonin receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentRegistration
Standard IndicationOsteoporosis
Indication DetailsPrevent postmenopausal osteoporosis; Treat osteoporosis; Treat postmenopausal osteoporosis
Regulatory Designation U.S. - Special Protocol Assessment (Treat postmenopausal osteoporosis)
PartnerEnteris BioPharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$9.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/26/2009

Undisclosed

$9.0M

Undisclosed

Get a free BioCentury trial today